Acadian Asset Management
ELDN icon

Acadian Asset Management’s Eledon Pharmaceuticals ELDN Stock Holding History

Acadian Asset Management’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1
Closed – – 2048
2021
Q1 		$0 Hold
1
– – ﹤0.01% 2128
2020
Q4 		$0 Sell
1
-9,453
-100% -$180K ﹤0.01% 2233
2020
Q3 		$162K Buy
9,454
+3,442
+57% +$33.9K ﹤0.01% 1526
2020
Q2 		$49K Buy
+6,012
New +$67.8K ﹤0.01% 1924

Other funds holding ELDN

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management's ELDN Position: Q2 2021 in Review

Acadian Asset Management sold out of Eledon Pharmaceuticals (ELDN) in Q2 2021, closing a stake of 1 share.

Acadian Asset Management first reported a position in ELDN in Q2 2020 and held it in 4 quarters. The position peaked at $162K in Q3 2020. 34 funds tracked by Wall St. Rank hold ELDN as of Q2 2021.

  • Acadian Asset Management reported no remaining Eledon Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Acadian Asset Management sold 1 Eledon Pharmaceuticals share in Q2 2021.
  • Acadian Asset Management first reported a position in Eledon Pharmaceuticals in Q2 2020 and held it in 4 quarters.
  • Acadian Asset Management's Eledon Pharmaceuticals position peaked at $162K in Q3 2020.
  • 34 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2021.

Based on Acadian Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.